Stories are generated from ORTEX data and reviewed by the ORTEX team. How we publish
Penguin Solutions delivered its quarterly results on October 6, and the Street's response the following morning was swift and one-directional: analysts scrambled to raise price targets, leaving short sellers who held through the print in an increasingly uncomfortable spot.
The analyst reaction tells the clearest story of the day. Three firms raised targets within hours of each other on October 7. Rosenblatt lifted its Buy target from $80 to $100, the most bullish call on the table. Stifel and Needham both moved to $85, up from $75 and $80 respectively, each keeping Buy ratings. The outlier is Barclays, which raised its target from $40 to $60 while holding an Underweight, a grudging acknowledgment that the stock has moved beyond what its bear case assumed. The mean analyst target now runs at $83.57, below the current price of $64.21, though with Rosenblatt's $100 and the Barclays $60 anchor pulling in opposite directions, the target spread is wide. The bull case centres on AI-driven revenue now making up 74% of sales and growing 104% year-on-year, alongside an Integrated Memory operating margin that recovered from roughly 5% in late FY2024 to 23% in the third quarter of FY26. Bears point to the Penguin Edge wind-down, the loss of Meta hardware revenue, and management's own caveat that more meaningful upside may not arrive until the second half of FY27.
Short positioning entered earnings at 13.2% of the free float, genuinely elevated, but the lending market offered no squeeze pressure to match. Availability has expanded further to 940%, up around 20% on the week, meaning the pool of shares available to borrow dwarfs the existing short position by nearly ten to one. The cost to borrow is just 0.41%, essentially negligible. Short sellers trimmed by about 2% over the past week ahead of the print, and with the stock up 15% on the week and 24% over the past month, those who held through are sitting on material losses. The ORTEX short score has drifted lower all week, from 53.5 on October 1 to 51.8 by October 6, reflecting easing short-side pressure rather than any acceleration of bearish conviction. Options positioning is almost exactly in line with its 20-day average, with the put/call ratio at 0.57 against a mean of 0.57, suggesting no unusual hedging demand in either direction after the number.
Valuation has re-rated sharply over the past month. The price-to-earnings multiple has expanded by roughly 3 points over 30 days to 16.8x, and price-to-book has moved up by nearly a full turn to 5.2x. EV/EBITDA is at 9.9x, up about 0.4 points over the same period. These are meaningful moves for a name that was still being written off as a cyclical memory trade not long ago. The EV/EBIT factor scores in the 71st percentile, and the dividend score ranks in the 77th, suggesting the valuation re-rating has not yet pushed the stock into obviously stretched territory on all measures. The short score rank of 20 out of 100 reflects that short positioning, while elevated in absolute terms, has been coming off.
One ownership angle worth flagging: SK Telecom holds a 10.3% stake via a Schedule 13D filing, last amended in July 2026. A 13D designation means the filer has declared active intent, making SK Telecom the most structurally significant holder on the register beyond the passive index complex. BlackRock holds 14.4% on a passive 13G basis, and FMR added over 1.5 million shares in its most recently reported period to reach a 12% position. The concentration of ownership is notable: the top three holders account for roughly 37% of shares, which compresses the effective free float available to short sellers even as borrow availability remains loose.
Retail attention has also picked up sharply. Wikipedia page views and ORTEX stock-page traffic together produced a z-score of 2.4 against the prior 90 days, one of the stronger retail-attention readings the alt data layer flags, as of late September. That was before the earnings catalyst.
The next scheduled print is in early January 2027, which leaves roughly three months for the Street to recalibrate whether management's "more meaningful upside in 2HFY27" commentary is credible, and whether the shorts who remain at 13% of the float choose to hold or cover into any further strength.
See the live data behind this article on ORTEX.
Open PENG on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.
